314.60DKK-1.05%Mkt Cap: 202.85B $P/E: 11.481d ago
Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products. It operates through two segments, Obesity and Diabetes Care, and Rare D…
Industry Peers
Drug Manufacturers - Generalvs Drug Manufacturers - General
P/E
Cheaper
P/B
Avg
Div Yield
Lower
1M Perf
Avg
$1.07TUSDP/E 42.6
$611.36BUSDP/E 29.4
$444.21BUSDP/E 123.9
$308.01BUSDP/E 21.1
$317.37BUSDP/E 36.2
$281.52BUSDP/E 22.5
$275.65BUSDP/E 22.4
$269.91BUSDP/E 28.1
$237.69BUSDP/E 28.0
$195.44BUSDP/E 25.2
$156.86BUSDP/E 17.2
$137.24BUSDP/E 18.4
$117.66BUSDP/E 16.1
$97.68BUSDP/E 19.0
$86.27BUSDP/E 14.0
$51.69BUSD
$31.90BUSDP/E 23.3
MRV
Marvell Technology, Inc.$30.93BUSDP/E 11.7
$11.35BUSDP/E 22.7
$11.02BUSDP/E 19.1
$10.98BUSDP/E 19.1
$6.60BUSDP/E 14.6
$3.56BUSDP/E 14.6
$3.03BUSDP/E 18.5
$54.86MUSD
$39.77MUSD
ELXR
Elixxer Ltd.$9.51MUSD
PHOO
Photocure ASA—
CELG-RI
Bristol-Myers Squibb Company Ce—
FLXN
Horizon Flexible Income ETF—P/E 27.2
ROSE
DocMorris AG—
Indicators:|
Key Statistics
Company
Market Cap202.85B $
Enterprise Value221.74B $
Revenue (TTM)47.74B $
Gross Profit36.45B $
Net Income (TTM)14.92B $
Revenue/Share10.74 USD
Last Price314.60 DKK
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees67.9K
CountryDK
SectorHealthcare
IndustryDrug Manufacturers - General
ISINUS6701002056
Valuation
P/E (Trailing)11.48
P/E (Forward)14.70
PEG3.57
EV/EBITDA8.76
EV/Revenue4.64
P/S4.25
P/B6.88
EPS (TTM)27.40
EPS (Forward)21.40
52W Range
224.2538% of range464.60
52W High464.60 DKK
52W Low224.25 DKK
Profitability
Gross Margin80.98%
Oper. Margin61.57%
EBITDA Margin53.04%
Profit Margin33.14%
ROE52.79%
ROA18.87%
Growth
Revenue Growth24.00%
Earnings Growth67.10%
Cash Flow & Leverage
Operating CF17.35B $
CapEx (TTM)13.13B $
FCF Margin-3.67%
FCF Yield-0.86%
Net Debt18.17B $
Net Debt/EBITDA0.72
Balance Sheet
Debt/Equity0.67
Current Ratio0.79
Quick Ratio0.54
Book Value/Sh45.71 DKK
Cash/Share4.868 DKK
Dividends
Fwd Div Rate15.90 DKK
Trail. Div Rate11.70 DKK
Div. Yield5.05%
5Y Avg Yield1.81%
Payout Ratio42.69%
Ex-Div DateMar 27, 2026
Pay Date—
Splits
Last Split2:1
Split DateSep 13, 2023
Analyst Consensus
Rating2.6 (Hold)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)314.62 DKK
Upside (mean)+0.0%
Target Range200.00 DKK – 454.00 DKK
DKK200.00+0.0% to meanDKK454.00
# Analysts24
Ownership
Shares Out.3.35B
Float3.19B
Insiders5.28%
Institutions33.09%
Technical
SMA 50284.02 (+10.8%)
SMA 200306.52 (+2.6%)
Beta0.35
S&P 52W Chg20.05%
Avg Vol (30d)5.32M
Avg Vol (10d)4.98M
Technical Indicators
RSI (14)65.6
MACD9.1243
MACD Signal5.9311
MACD Hist.+3.1932
BB Upper321.23 DKK
BB Middle290.23 DKK
BB Lower259.23 DKK
BB Width21.36%
ATR (14)9.963 DKK
Vol Ratio (20d)0.80x